Tilray Brands (TLRY) News
Latest news and analysis
Tilray's Path to Profitability Faces Mounting Headwinds
Cannabis giant Tilray continues burning cash as regulatory delays and competitive pressures challenge the company's timeline for achieving sustainable profitability.
TLRY's Shrinking Losses Hide Profitability Challenges Ahead
Tilray's reduced quarterly losses mask underlying operational struggles as the cannabis giant faces headwinds to sustainable profitability.
Tilray Stock Gains Momentum as Cannabis Fundamentals Strengthen
TLRY shares climb as improving operational metrics and strategic positioning drive renewed investor confidence in the diversified cannabis operator.
Tilray Cannabis Revenue Surge Drives Jefferies Price Target Boost
Strong cannabis segment performance and positive guidance outlook prompt analysts to maintain bullish stance on TLRY shares amid sector headwinds.
Tilray's Multi-Vertical Strategy Faces Profitability Test in 2024
TLRY trades at steep discount despite revenue diversification, but path to sustainable profits remains unclear as cannabis margins compress industry-wide.
Tilray Q3 Earnings: Cannabis Giant Faces Revenue Headwinds
TLRY reports mixed Q3 results as cannabis revenue declines offset beverage growth, raising questions about path to profitability in challenging market.
Tilray Posts Record Q3 Revenue as International Cannabis Surges 73%
TLRY reports $207M quarterly revenue with 11% organic growth, driven by explosive international expansion and strong flower sales volume gains.
Tilray Brands Surges 8.9% as Cannabis Giant Eyes Market Recovery
TLRY shares jumped to $7.02 on elevated volume, marking a significant rebound for the cannabis operator amid sector-wide momentum.
TLRY Under Pressure as Cannabis Volatility Triggers Wall Street Concerns
Tilray faces intensified analyst scrutiny as broader cannabis sector turbulence weighs on investor confidence and stock performance.
Tilray Stock Under Pressure as Cannabis Sector Volatility Intensifies
TLRY faces mounting analyst pressure amid broader cannabis market turbulence, raising questions about near-term performance outlook.